BNTC
Benitec Biopharma Inc.
NASDAQ · Healthcare · Biotechnology · US
$12.68
+1.93%Next report
Analyst consensus
- Next report date
- Sep 28, 2026
- EPS estimate
- -$0.26
- Revenue estimate
- —
Latest reported
- Last report date
- May 14, 2026
- EPS actual
- -$0.24
- EPS estimate
- -$0.27
- Revenue actual
- —
- Revenue estimate
- $4.5M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -3.7%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 28, 2026